These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25280384)

  • 1. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways.
    Nazir N; Siddiqui K; Al-Qasim S; Al-Naqeb D
    BMC Med Genet; 2014 Oct; 15():103. PubMed ID: 25280384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.
    Raina P; Sikka R; Gupta H; Matharoo K; Bali SK; Singh V; Bhanwer A
    Biochem Genet; 2021 Aug; 59(4):966-996. PubMed ID: 33609191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.
    Ahluwalia TS; Khullar M; Ahuja M; Kohli HS; Bhansali A; Mohan V; Venkatesan R; Rai TS; Sud K; Singal PK
    PLoS One; 2009; 4(4):e5168. PubMed ID: 19357773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of monocyte chemoattractant protein-1 2518G/A gene polymorphism with diabetic nephropathy risk.
    Su N; Li HY; Huang MF; Jiang ZP; Zhou TB
    J Recept Signal Transduct Res; 2015 Feb; 35(1):94-7. PubMed ID: 25051493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.
    Hameed I; Masoodi SR; Malik PA; Mir SA; Ghazanfar K; Ganai BA
    Gene; 2018 Jun; 661():51-59. PubMed ID: 29605608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic associations in diabetic nephropathy: a meta-analysis.
    Mooyaart AL; Valk EJ; van Es LA; Bruijn JA; de Heer E; Freedman BI; Dekkers OM; Baelde HJ
    Diabetologia; 2011 Mar; 54(3):544-53. PubMed ID: 21127830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in
    Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
    Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis.
    Sun L; Yuan Q; Cao N; Guo W; Yao L; Feng JM; Ma JF; Wang LN
    ScientificWorldJournal; 2014; 2014():624573. PubMed ID: 25184149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.
    Tziastoudi M; Stefanidis I; Hadjigeorgiou GM; Stravodimos K; Zintzaras E
    Clin Kidney J; 2017 Jun; 10(3):293-300. PubMed ID: 28616206
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-Analysis and Bioinformatics Detection of Susceptibility Genes in Diabetic Nephropathy.
    Tziastoudi M; Cholevas C; Theoharides TC; Stefanidis I
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms of cytokine genes and diabetic nephropathy: A comprehensive systematic review and meta-analysis.
    Wu J; Jiang C; Hua Y; Liu X; You C
    Int J Clin Pract; 2021 Nov; 75(11):e14634. PubMed ID: 34309136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.
    Stefanidis I; Tziastoudi M; Tsironi EE; Dardiotis E; Tachmitzi SV; Fotiadou A; Pissas G; Kytoudis K; Sounidaki M; Ampatzis G; Mertens PR; Liakopoulos V; Eleftheriadis T; Hadjigeorgiou GM; Santos M; Zintzaras E
    Ren Fail; 2018 Nov; 40(1):561-576. PubMed ID: 30353771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis.
    Dellamea BS; Pinto LC; Leitão CB; Santos KG; Canani LH
    BMC Med Genet; 2014 Jan; 15():9. PubMed ID: 24433471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy.
    Pettigrew KA; McKnight AJ; Patterson CC; Kilner J; Sadlier DM; Maxwell AP
    J Hum Genet; 2010 Apr; 55(4):248-51. PubMed ID: 20203694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis.
    Tziastoudi M; Theoharides TC; Nikolaou E; Efthymiadi M; Eleftheriadis T; Stefanidis I
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
    Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
    Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies.
    Tziastoudi M; Stefanidis I; Zintzaras E
    Clin Kidney J; 2020 Oct; 13(5):768-781. PubMed ID: 33123356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of angiotensin-converting enzyme insertion/deletion polymorphism with type 1 diabetic nephropathy: a meta-analysis.
    Xu HY; Liu MM; Wang X; He XY
    Ren Fail; 2016 Oct; 38(9):1320-1327. PubMed ID: 27498976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.